Home
Schedule
Meeting Information
Hotel Information
Instructors Only
Contact Us



 
Program
Keynote
Plant Tour
Exhibitors
Sponsors
Media Partners

ASME Contact:
Jennifer Delda
Program Manager
212-591-7108
deldaj@asme.org



 


PD485: Validation of Biopharmaceutical Facilities & Processes


This course is now available on CD-ROM. To purchase, please call 800-843-2763.




This is an advanced level course.


Description


Validation of facilities, equipment and critical process steps utilized for the manufacture of biological products is required in order to comply with regulatory requirements from government agencies such as the US Food and Drug Administration. The design and execution of an adequate validation program will assure that the facilities used in manufacturing are appropriately established and maintained conforming to design specifications and the production process is under an appropriate state of control. These elements represent a key contribution to assuring the final quality of the biological product manufactured.

This course presents a detailed discussion of the approaches that a biopharmaceutical company can take in order to implement a validation program that will achieve the ultimate goal of complying with the regulatory requirements for validation in an evolving environment. Examples from real case situations will be used to demonstrate such approaches and to guide participants through lessons learned by experienced practitioners.

What You Will Learn

  • An integrated view of the validation efforts required of a biopharmaceutical manufacturer
  • Workable approaches for implementing a validation program
  • Examples of Validation Master Plan and validation protocol preparation
  • The latest trends in FDA regulatory requirements and their relationship to validation
  • Strategic thinking skills toward the validation exercises
  • How to ask the right questions during validation


Who Should Attend

This course is intended for individuals who are involved with manufacturing, quality functions, engineering, validation, and process development for biological products. Such individuals can be involved with the design and construction of a biopharmaceutical facility, the development, operation, and validation of a bio-manufacturing process, or preparation for licensure.

Schedule

Sunday, October 22, 2006
5:00 pm - 8:30 pm Registration Open - Avoid the lines on Monday!
Monday, October 23, 2006
7:30 am - 8:30 am Registration Desk Open / Continental Breakfast
8:30 am - 10:00 am
Principles of Validation
This lecture provides the general background for the course. It includes the key concepts and definitions of validation and identifies the various approaches that can be taken towards the validation exercise.
Antonio Moreira
Vice Provost, UMBC, & Executive Vice President, SPI USA, Inc.
10:00 am - 10:30 am
Refreshment Break
10:30 am - 12:00 noon
Validation Master Plan
As the first step toward successful validation, many companies develop a Validation Master Plan that sets out the validation scope, responsibilities and schedule. This lecture describes what is typ1ically included in the master plan, how to prepare one, and its value to the validation process.
Alison Demarest
Consultant
12:00 noon - 1:00 pm
Lunch
1:00 pm - 2:30 pm
Preparation of Validation Documents and Protocols
Adequate and accurate documentation of the validation program is of paramount importance to a successful outcome and ultimate acceptance by the FDA of the validation data. This lecture provides examples of format and content of various validation documents, outlines responsibilities for preparation and execution, and addresses in-house execution versus subcontracted validation.
Alison Demarest
Consultant
2:30 pm - 3:00 pm
Refreshment Break
3:00 pm - 4:30 pm
Facilities Validation: HVAC Systems
HVAC systems represent one of the key operational systems in any biotechnology facility. This segment describes in-depth aspects related to validation of such systems from initial installation to ongoing operation.
Marta Murray
Associate Director,
Q.A. Engineering
Kos Pharmaceuticals, Inc.
4:30 pm - 5:30 pm KEYNOTE Presentation
5:30 pm - 7:00 pm Opening Reception w/ Exhibitors
Tuesday, October 24, 2006
7:30 am - 8:30 am Registration Desk Open / Continental Breakfast w/ Exhibitors
8:30 am - 10:00 am Facilities Validation: High Purity Water Systems
Systems for the production of biopharmaceutical process water represent another key component of a manufacturing facility. This lecture discusses the installation, operational and performance qualification of water systems, including the common test elements, types of data to be collected, the frequency and duration of testing, and validation pitfalls.

Rich Yeaton
President, East Coast Validation Services, LLC

10:00 am - 10:30 am
Refreshment Break w/ Exhibitors
10:30 am - 11:15 am Validation Issues with Disposable Equipment
The use of disposable equipment is attracting increased attention from biopharmaceutical manufacturers due to the perceived decreased validation requirements with single use items. However, other concerns surface such as the presence of leachables, equipment integrity, etc. A summary of the current approached for handling disposable systems will be presented.
Antonio Moreira
Vice Provost, UMBC, & Executive Vice President, SPI USA, Inc.
11:15 am - 12:00 noon Case Study on Part 11 Compliance
The use of automation and computerization systems is of central importance in the bio-manufacturing environment. Such systems are potentially under a requirement for compliance with Part 11 depending on how the information obtained is used for decision making and FDA reporting. A case study on Part 11 compliance will be presented.
Rich Yeaton
President, East Coast Validation Services, LLC
12:00 noon - 1:00 pm
Lunch w/ Exhibitors
1:00 pm - 2:30 pm
Validation of Bioprocessing Equipment
A wide variety of processing equipment is utilized in a typical bio-manufacturing facility. This equipment includes bioreactors, filtration skids, centrifuges, chromatography columns, etc. Validation approaches for these types of equipment and examples of data that needs to be collected are presented in this lecture.
Antonio Moreira
Vice Provost, UMBC, & Executive Vice President, SPI USA, Inc.
2:30 pm - 3:00 pm
Refreshment Break w/ Exhibitors
3:00 pm - 4:30 pm
Validation of Steam Sterilization Processes
Steam sterilization is a critical operation in any bio-manufacturing process, including sterilize-in-place process equipment such bioreactors and filtration equipment, as well as support equipment such as autoclaves. This lecture will discuss the development of validation protocols for these systems and the establishment of achievable acceptance criteria.
Rich Yeaton
President, East Coast Validation Services, LLC
Wednesday, October, 25, 2006
7:30 am - 8:30 am Registration Desk Open / Continental Breakfast w/ Exhibitors
8:30 am - 10:00 am
Validation of Bioprocesses
This lecture describes approaches that can be taken for validation of the main steps that typically compose a bio-manufacturing process. These include cell banking, fermentation/cell culture, early recovery steps, and chromatographic separations. The critical issues that need to be addressed are identified.
Antonio Moreira
Vice Provost, UMBC, & Executive Vice President, SPI USA, Inc.
10:00 am - 10:30 am
Refreshment Break w/ Exhibitors
10:30 am - 12:00 noon
Cleaning Validation
This lecture describes the considerations that need to be addressed when designing and validating cleaning of the process equipment utilized in bio-manufacturing systems. Goals of the cleaning program, types of residues that need to be considered, and mechanisms/approaches for cleaning are included. CIP systems are discussed.
Marta Murray
Associate Director,
Q.A. Engineering
Kos Pharmaceuticals, Inc.
12:00 noon - 1:00 pm
Lunch w/ Exhibitors
1:00 pm - 2:30 pm
Validation of Removal of Process Contaminants
Removal and/or inactivation of the viral contamination that can occur in cell culturing processes constitute a key regulatory concern. Also of major concern is the removal of nucleic acids and endotoxin contaminants. This lecture describes approaches for achieving validation of the removal of these contaminants and discusses current trends with example data.
Antonio Moreira
Vice Provost, UMBC, & Executive Vice President, SPI USA, Inc.
2:30 pm - 3:00 pm
Refreshment Break w/ Exhibitors
3:00 pm - 4:00 pm
Re-Validation Strategies
This segment will present a discussion on how to approach periodic re-validation of systems, equipment and processes. This includes ongoing validation as well as change-driven validation. FDA expectations and specific examples will be included.
Alison Demarest
Consultant
Thursday, October 26, 2006
4:00 pm - 5:30 pm
PLANT TOUR: BRI Bioprocess Plant - 50 Maximum
Friday, October 27, 2006
9:00 am - 10:30 am
PLANT TOUR: BRI Bioprocess Plant - 50 Maximum

 


ASME Travel Policy : ASME is not responsible for the purchase of non-refundable airline tickets or the cancellation/change fees associated with canceling a flight. Please call to confirm that the course is running before purchasing airline tickets. ASME retains the right to cancel a course up until 3 weeks of the scheduled presentation date.


 
Produced By
 
 
ASME
 
Premier Media Sponsor
Corporate Sponsor
Supporting Organization
Supporting Publications
ASME Sponsoring Divisions 
           

Copyright © 1996-2008 ASME. All Rights Reserved. Terms of Use | Privacy Statement
Powered by Conference Toolbox ™ version 4.0. For more information, contact us.